Tapewire

Nasdaq · USD

VIR

Vir Biotechnology, Inc.

Export transactions ↓
Tapewire entity
4522
SEC CIK
0001706431
Parsed reports
486

Last 12 months

Inside the activity.

0 purchase rows · 35 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202508
Dec 202502
Jan 202601
Feb 2026016
Mar 202603
Apr 202602
May 202601
Jun 202602
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 21, 2021 Filed May 25, 2021 20:47 UTC GrantCommon Stock 3,374 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-035715 · doc4.xml · nonDerivative · entry 1

Ramasastry Saira · CIK 0001547959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,374

Read SEC document
May 21, 2021 Filed May 25, 2021 20:46 UTC GrantStock Option (Right to Buy) · Derivative 6,748 $0.00 Strike: $45.28 $0.00
Disclosure

SEC source: 0001209191-21-035713 · doc4.xml · derivative · entry 2

PEREZ ROBERT J · CIK 0001263230 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,748

Underlying: Common Stock · 6,748 shares

Expires 2031-05-20

Read SEC document
May 21, 2021 Filed May 25, 2021 20:46 UTC GrantCommon Stock 3,374 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-035713 · doc4.xml · nonDerivative · entry 1

PEREZ ROBERT J · CIK 0001263230 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,374

Read SEC document
May 21, 2021 Filed May 25, 2021 20:45 UTC GrantStock Option (Right to Buy) · Derivative 6,748 $0.00 Strike: $45.28 $0.00
Disclosure

SEC source: 0001209191-21-035712 · doc4.xml · derivative · entry 2

Nishar Dipchand · CIK 0001519500 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,748

Underlying: Common Stock · 6,748 shares

Expires 2031-05-20

Read SEC document
May 21, 2021 Filed May 25, 2021 20:45 UTC GrantCommon Stock 3,374 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-035712 · doc4.xml · nonDerivative · entry 1

Nishar Dipchand · CIK 0001519500 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,374

Read SEC document
May 21, 2021 Filed May 25, 2021 20:44 UTC
NELSEN ROBERTDirector · 10% owner
GrantStock Option (Right to Buy) · Derivative 6,748 $0.00 Strike: $45.28 $0.00
Disclosure

SEC source: 0001209191-21-035711 · doc4.xml · derivative · entry 4

NELSEN ROBERT · CIK 0001219042 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,748

Underlying: Common Stock · 6,748 shares

Expires 2031-05-20

Read SEC document
May 21, 2021 Filed May 25, 2021 20:44 UTC
NELSEN ROBERTDirector · 10% owner
GrantCommon Stock 3,374 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-035711 · doc4.xml · nonDerivative · entry 1

NELSEN ROBERT · CIK 0001219042 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,328

Read SEC document
May 21, 2021 Filed May 25, 2021 20:40 UTC GrantStock Option (Right to Buy) · Derivative 6,748 $0.00 Strike: $45.28 $0.00
Disclosure

SEC source: 0001209191-21-035710 · doc4.xml · derivative · entry 2

Napolitano Janet · CIK 0001821008 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,748

Underlying: Common Stock · 6,748 shares

Expires 2031-05-20

Read SEC document
May 21, 2021 Filed May 25, 2021 20:40 UTC GrantCommon Stock 3,374 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-035710 · doc4.xml · nonDerivative · entry 1

Napolitano Janet · CIK 0001821008 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,374

Read SEC document
May 21, 2021 Filed May 25, 2021 20:38 UTC GrantStock Option (Right to Buy) · Derivative 6,748 $0.00 Strike: $45.28 $0.00
Disclosure

SEC source: 0001209191-21-035709 · doc4.xml · derivative · entry 3

MORE ROBERT J · CIK 0001207792 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,748

Underlying: Common Stock · 6,748 shares

Expires 2031-05-20

Read SEC document
May 21, 2021 Filed May 25, 2021 20:38 UTC GrantCommon Stock 3,374 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-035709 · doc4.xml · nonDerivative · entry 1

MORE ROBERT J · CIK 0001207792 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,709

Read SEC document
May 21, 2021 Filed May 25, 2021 20:35 UTC GrantStock Option (Right to Buy) · Derivative 6,748 $0.00 Strike: $45.28 $0.00
Disclosure

SEC source: 0001209191-21-035706 · doc4.xml · derivative · entry 2

Hatfield Jeffrey S. · CIK 0001609879 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,748

Underlying: Common Stock · 6,748 shares

Expires 2031-05-20

Read SEC document
May 21, 2021 Filed May 25, 2021 20:35 UTC GrantCommon Stock 3,374 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-035706 · doc4.xml · nonDerivative · entry 1

Hatfield Jeffrey S. · CIK 0001609879 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,374

Read SEC document
May 21, 2021 Filed May 25, 2021 20:34 UTC
SATO VICKI LDirector
GrantStock Option (Right to Buy) · Derivative 6,748 $0.00 Strike: $45.28 $0.00
Disclosure

SEC source: 0001209191-21-035702 · doc4.xml · derivative · entry 2

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,748

Underlying: Common Stock · 6,748 shares

Expires 2031-05-20

Read SEC document
May 21, 2021 Filed May 25, 2021 20:34 UTC
SATO VICKI LDirector
GrantCommon Stock 3,374 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-035702 · doc4.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,657,310

Read SEC document
May 20, 2021 Filed May 25, 2021 01:25 UTC SaleCommon Stock 9,095 $44.77 $407,153.14
Disclosure

SEC source: 0001209191-21-035596 · doc4.xml · nonDerivative · entry 2

MORE ROBERT J · CIK 0001207792 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,335

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2021.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.22 to $45.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
May 20, 2021 Filed May 25, 2021 01:25 UTC SaleCommon Stock 2,575 $43.57 $112,198.16
Disclosure

SEC source: 0001209191-21-035596 · doc4.xml · nonDerivative · entry 1

MORE ROBERT J · CIK 0001207792 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,430

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.16 to $44.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F3 · balance_after: Includes 30,354 shares received in a pro-rata distribution from Alta Partners NextGen Fund I, L.P. (APNG 1) which was effected on April 5, 2021.

Read SEC document
May 19, 2021 Filed May 20, 2021 23:54 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $12.76 $0.00
Disclosure

SEC source: 0001209191-21-034668 · doc4.xml · derivative · entry 3

Ramasastry Saira · CIK 0001547959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,777

Underlying: Common Stock · 10,000 shares

Expires 2029-12-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/3 of the shares subject to the stock option vested and became exercisable on September 4, 2020, and the remaining shares vest in 24 equal monthly installments thereafter.

Read SEC document
May 19, 2021 Filed May 20, 2021 23:54 UTC SaleCommon Stock 10,000 $43.73 $437,275.00
Disclosure

SEC source: 0001209191-21-034668 · doc4.xml · nonDerivative · entry 2

Ramasastry Saira · CIK 0001547959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2021.

Read SEC document
May 19, 2021 Filed May 20, 2021 23:54 UTC Exercise / conversionCommon Stock 10,000 $12.76 $127,600.00
Disclosure

SEC source: 0001209191-21-034668 · doc4.xml · nonDerivative · entry 1

Ramasastry Saira · CIK 0001547959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 19, 2021 Filed May 20, 2021 23:53 UTC
SATO VICKI LDirector
SaleCommon Stock 1,443 $44.96 $64,877.28
Disclosure

SEC source: 0001209191-21-034665 · doc4.xml · nonDerivative · entry 3

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,653,936

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2021.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.88 to $45.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
May 19, 2021 Filed May 20, 2021 23:53 UTC
SATO VICKI LDirector
SaleCommon Stock 5,403 $44.18 $238,704.54
Disclosure

SEC source: 0001209191-21-034665 · doc4.xml · nonDerivative · entry 2

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,655,379

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2021.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.84 to $44.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
May 19, 2021 Filed May 20, 2021 23:53 UTC
SATO VICKI LDirector
SaleCommon Stock 8,328 $43.35 $361,018.80
Disclosure

SEC source: 0001209191-21-034665 · doc4.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,660,782

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.77 to $43.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
May 18, 2021 Filed May 19, 2021 20:39 UTC
Virgin HerbertEVP, Research & CSO
Exercise / conversionStock Option (Right to Buy) · Derivative 1,375 $0.00 Strike: $1.53 $0.00
Disclosure

SEC source: 0001209191-21-034017 · doc4.xml · derivative · entry 3

Virgin Herbert · CIK 0001786378 · EVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 301,505

Underlying: Common Stock · 1,375 shares

Expires 2028-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
May 18, 2021 Filed May 19, 2021 20:39 UTC
Virgin HerbertEVP, Research & CSO
SaleCommon Stock 1,375 $45.03 $61,916.25
Disclosure

SEC source: 0001209191-21-034017 · doc4.xml · nonDerivative · entry 2

Virgin Herbert · CIK 0001786378 · EVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,700

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020.

Read SEC document
May 18, 2021 Filed May 19, 2021 20:39 UTC
Virgin HerbertEVP, Research & CSO
Exercise / conversionCommon Stock 1,375 $1.53 $2,103.75
Disclosure

SEC source: 0001209191-21-034017 · doc4.xml · nonDerivative · entry 1

Virgin Herbert · CIK 0001786378 · EVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,075

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2021 Filed May 5, 2021 23:36 UTC
Virgin HerbertEVP, Research & CSO
Exercise / conversionStock Option (Right to Buy) · Derivative 1,375 $0.00 Strike: $1.53 $0.00
Disclosure

SEC source: 0001209191-21-030485 · doc4.xml · derivative · entry 3

Virgin Herbert · CIK 0001786378 · EVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 302,880

Underlying: Common Stock · 1,375 shares

Expires 2028-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
May 04, 2021 Filed May 5, 2021 23:36 UTC
Virgin HerbertEVP, Research & CSO
SaleCommon Stock 1,375 $46.03 $63,291.25
Disclosure

SEC source: 0001209191-21-030485 · doc4.xml · nonDerivative · entry 2

Virgin Herbert · CIK 0001786378 · EVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,700

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020.

Read SEC document
May 04, 2021 Filed May 5, 2021 23:36 UTC
Virgin HerbertEVP, Research & CSO
Exercise / conversionCommon Stock 1,375 $1.53 $2,103.75
Disclosure

SEC source: 0001209191-21-030485 · doc4.xml · nonDerivative · entry 1

Virgin Herbert · CIK 0001786378 · EVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,075

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 27, 2021 Filed Apr 28, 2021 20:41 UTC
Virgin HerbertEVP, Research & CSO
Exercise / conversionStock Option (Right to Buy) · Derivative 7,900 $0.00 Strike: $1.53 $0.00
Disclosure

SEC source: 0001209191-21-028811 · doc4.xml · derivative · entry 3

Virgin Herbert · CIK 0001786378 · EVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 304,255

Underlying: Common Stock · 7,900 shares

Expires 2028-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
April 27, 2021 Filed Apr 28, 2021 20:41 UTC
Virgin HerbertEVP, Research & CSO
SaleCommon Stock 7,900 $49.50 $391,076.86
Disclosure

SEC source: 0001209191-21-028811 · doc4.xml · nonDerivative · entry 2

Virgin Herbert · CIK 0001786378 · EVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,700

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.4546 to $49.5295 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 27, 2021 Filed Apr 28, 2021 20:41 UTC
Virgin HerbertEVP, Research & CSO
Exercise / conversionCommon Stock 7,900 $1.53 $12,087.00
Disclosure

SEC source: 0001209191-21-028811 · doc4.xml · nonDerivative · entry 1

Virgin Herbert · CIK 0001786378 · EVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,600

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 19, 2021 Filed Apr 20, 2021 22:18 UTC
Virgin HerbertEVP, Research & CSO
Exercise / conversionStock Option (Right to Buy) · Derivative 2,340 $0.00 Strike: $1.53 $0.00
Disclosure

SEC source: 0001209191-21-027614 · doc4.xml · derivative · entry 3

Virgin Herbert · CIK 0001786378 · EVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 312,155

Underlying: Common Stock · 2,340 shares

Expires 2028-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
April 19, 2021 Filed Apr 20, 2021 22:18 UTC
Virgin HerbertEVP, Research & CSO
SaleCommon Stock 2,340 $48.00 $112,320.00
Disclosure

SEC source: 0001209191-21-027614 · doc4.xml · nonDerivative · entry 2

Virgin Herbert · CIK 0001786378 · EVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,700

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020.

Read SEC document
April 19, 2021 Filed Apr 20, 2021 22:18 UTC
Virgin HerbertEVP, Research & CSO
Exercise / conversionCommon Stock 2,340 $1.53 $3,580.20
Disclosure

SEC source: 0001209191-21-027614 · doc4.xml · nonDerivative · entry 1

Virgin Herbert · CIK 0001786378 · EVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,040

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 16, 2021 Filed Apr 20, 2021 00:00 UTC
Virgin HerbertEVP, Research & CSO
Exercise / conversionStock Option (Right to Buy) · Derivative 3,500 $0.00 Strike: $1.53 $0.00
Disclosure

SEC source: 0001209191-21-027425 · doc4.xml · derivative · entry 2

Virgin Herbert · CIK 0001786378 · EVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 314,495

Underlying: Common Stock · 3,500 shares

Expires 2028-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
April 16, 2021 Filed Apr 20, 2021 00:00 UTC
Virgin HerbertEVP, Research & CSO
Exercise / conversionCommon Stock 3,500 $1.53 $5,355.00
Disclosure

SEC source: 0001209191-21-027425 · doc4.xml · nonDerivative · entry 1

Virgin Herbert · CIK 0001786378 · EVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,700

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 13, 2021 Filed Apr 15, 2021 21:36 UTC
Virgin HerbertEVP, Research & CSO
Exercise / conversionStock Option (Right to Buy) · Derivative 5,560 $0.00 Strike: $1.53 $0.00
Disclosure

SEC source: 0001209191-21-026858 · doc4.xml · derivative · entry 3

Virgin Herbert · CIK 0001786378 · EVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 317,995

Underlying: Common Stock · 5,560 shares

Expires 2028-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
April 13, 2021 Filed Apr 15, 2021 21:36 UTC
Virgin HerbertEVP, Research & CSO
SaleCommon Stock 5,560 $43.57 $242,244.20
Disclosure

SEC source: 0001209191-21-026858 · doc4.xml · nonDerivative · entry 2

Virgin Herbert · CIK 0001786378 · EVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,200

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.5286 to $43.6146 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 13, 2021 Filed Apr 15, 2021 21:36 UTC
Virgin HerbertEVP, Research & CSO
Exercise / conversionCommon Stock 5,560 $1.53 $8,506.80
Disclosure

SEC source: 0001209191-21-026858 · doc4.xml · nonDerivative · entry 1

Virgin Herbert · CIK 0001786378 · EVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,760

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 09, 2021 Filed Apr 13, 2021 00:23 UTC
Virgin HerbertEVP, Research & CSO
Exercise / conversionStock Option (Right to Buy) · Derivative 14,000 $0.00 Strike: $1.53 $0.00
Disclosure

SEC source: 0001209191-21-026392 · doc4.xml · derivative · entry 2

Virgin Herbert · CIK 0001786378 · EVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 323,555

Underlying: Common Stock · 14,000 shares

Expires 2028-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
April 09, 2021 Filed Apr 13, 2021 00:23 UTC
Virgin HerbertEVP, Research & CSO
Exercise / conversionCommon Stock 14,000 $1.53 $21,420.00
Disclosure

SEC source: 0001209191-21-026392 · doc4.xml · nonDerivative · entry 1

Virgin Herbert · CIK 0001786378 · EVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 08, 2021 Filed Apr 9, 2021 21:07 UTC
BYBEE CLINTON10% owner
OtherCommon Stock 1,019 $0.00 $0.00
Disclosure

SEC source: 0001062993-21-003536 · form4.xml · nonDerivative · entry 8

ARCH Venture Partners IX, LLC · CIK 0001723174 · 10% owner

ARCH Venture Partners IX, L.P. · CIK 0001723173 · 10% owner

ARCH Venture Partners IX Overage, L.P. · CIK 0001723172 · 10% owner

ARCH Venture Fund IX, L.P. · CIK 0001666306 · 10% owner

ARCH Venture Fund IX Overage, L.P. · CIK 0001666307 · 10% owner

CRANDELL KEITH · CIK 0001219039 · 10% owner

BYBEE CLINTON · CIK 0001219043 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,068

F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration.

F4 · kind: Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person.

F6 · ownership.direct: Shares held directly by Bybee.

Read SEC document
April 08, 2021 Filed Apr 9, 2021 21:07 UTC
BYBEE CLINTON10% owner
OtherCommon Stock 3,161 $0.00 $0.00
Disclosure

SEC source: 0001062993-21-003536 · form4.xml · nonDerivative · entry 7

ARCH Venture Partners IX, LLC · CIK 0001723174 · 10% owner

ARCH Venture Partners IX, L.P. · CIK 0001723173 · 10% owner

ARCH Venture Partners IX Overage, L.P. · CIK 0001723172 · 10% owner

ARCH Venture Fund IX, L.P. · CIK 0001666306 · 10% owner

ARCH Venture Fund IX Overage, L.P. · CIK 0001666307 · 10% owner

CRANDELL KEITH · CIK 0001219039 · 10% owner

BYBEE CLINTON · CIK 0001219043 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,642

F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration.

F4 · kind: Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person.

F5 · ownership.direct: Shares held directly by Crandell.

Read SEC document
April 08, 2021 Filed Apr 9, 2021 21:07 UTC
BYBEE CLINTON10% owner
OtherCommon Stock 282,219 $0.00 $0.00
Disclosure

SEC source: 0001062993-21-003536 · form4.xml · nonDerivative · entry 6

ARCH Venture Partners IX, LLC · CIK 0001723174 · 10% owner

ARCH Venture Partners IX, L.P. · CIK 0001723173 · 10% owner

ARCH Venture Partners IX Overage, L.P. · CIK 0001723172 · 10% owner

ARCH Venture Fund IX, L.P. · CIK 0001666306 · 10% owner

ARCH Venture Fund IX Overage, L.P. · CIK 0001666307 · 10% owner

CRANDELL KEITH · CIK 0001219039 · 10% owner

BYBEE CLINTON · CIK 0001219043 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 15,051,678

F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration.

F3 · ownership.nature: These shares are directly held by ARCH Venture Fund IX Overage, L.P. ("ARCH Overage"). ARCH Venture Partners IX Overage, L.P. ("Overage GPLP"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.

Read SEC document
April 08, 2021 Filed Apr 9, 2021 21:07 UTC
BYBEE CLINTON10% owner
OtherCommon Stock 217,781 $0.00 $0.00
Disclosure

SEC source: 0001062993-21-003536 · form4.xml · nonDerivative · entry 5

ARCH Venture Partners IX, LLC · CIK 0001723174 · 10% owner

ARCH Venture Partners IX, L.P. · CIK 0001723173 · 10% owner

ARCH Venture Partners IX Overage, L.P. · CIK 0001723172 · 10% owner

ARCH Venture Fund IX, L.P. · CIK 0001666306 · 10% owner

ARCH Venture Fund IX Overage, L.P. · CIK 0001666307 · 10% owner

CRANDELL KEITH · CIK 0001219039 · 10% owner

BYBEE CLINTON · CIK 0001219043 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 11,614,985

F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration.

F2 · ownership.nature: These shares are directly held by ARCH Venture Fund IX, L.P. ("ARCH IX"). ARCH Venture Partners IX, L.P. ("GPLP"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the "ARCH Managing Directors"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.

Read SEC document
April 08, 2021 Filed Apr 9, 2021 21:08 UTC
NELSEN ROBERTDirector · 10% owner
OtherCommon Stock 5,989 $0.00 $0.00
Disclosure

SEC source: 0001062993-21-003537 · form4.xml · nonDerivative · entry 6

NELSEN ROBERT · CIK 0001219042 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,954

F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration.

F4 · kind: Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person.

Read SEC document
April 08, 2021 Filed Apr 9, 2021 21:08 UTC
NELSEN ROBERTDirector · 10% owner
OtherCommon Stock 282,219 $0.00 $0.00
Disclosure

SEC source: 0001062993-21-003537 · form4.xml · nonDerivative · entry 5

NELSEN ROBERT · CIK 0001219042 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 15,051,678

F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration.

F3 · ownership.nature: The shares are directly held by ARCH Venture Fund IX Overage, L.P. ("ARCH Overage"). The Reporting Person is a managing director of ARCH Venture Partners IX, LLC, the sole general partner of ARCH Venture Partners IX Overage, L.P. ("Overage GPLP"), which is the sole general partner of ARCH Overage, and shares voting and investment control with respect to shares held by ARCH Overage. The Reporting Person disclaims ownership of such shares, except to the extent of his pecuniary interest therein.

Read SEC document
April 08, 2021 Filed Apr 9, 2021 21:08 UTC
NELSEN ROBERTDirector · 10% owner
OtherCommon Stock 217,781 $0.00 $0.00
Disclosure

SEC source: 0001062993-21-003537 · form4.xml · nonDerivative · entry 4

NELSEN ROBERT · CIK 0001219042 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 11,614,985

F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration.

F2 · ownership.nature: The shares are held by ARCH Venture Fund IX, L.P. ("ARCH IX"). The Reporting Person is a managing director of ARCH Venture Partners IX, LLC, the sole general partner of ARCH Venture Partners IX, L.P., which is the sole general partner of ARCH IX, and shares voting and investment control with respect to shares held by ARCH IX. The Reporting Person may be deemed to beneficially own the shares held by ARCH IX, and the Reporting Person disclaims ownership of such shares, except to the extent of his pecuniary interest therein.

Read SEC document
April 07, 2021 Filed Apr 9, 2021 21:07 UTC
BYBEE CLINTON10% owner
OtherCommon Stock 1,019 $0.00 $0.00
Disclosure

SEC source: 0001062993-21-003536 · form4.xml · nonDerivative · entry 4

ARCH Venture Partners IX, LLC · CIK 0001723174 · 10% owner

ARCH Venture Partners IX, L.P. · CIK 0001723173 · 10% owner

ARCH Venture Partners IX Overage, L.P. · CIK 0001723172 · 10% owner

ARCH Venture Fund IX, L.P. · CIK 0001666306 · 10% owner

ARCH Venture Fund IX Overage, L.P. · CIK 0001666307 · 10% owner

CRANDELL KEITH · CIK 0001219039 · 10% owner

BYBEE CLINTON · CIK 0001219043 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,049

F1 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration.

F4 · kind: Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person.

F6 · ownership.direct: Shares held directly by Bybee.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.